Ping Li-Ping
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Advances in the Treatment of Diabetic Kidney Disease With Traditional Chinese Medicine.
Journal: Seminars in nephrology
Published: March 17, 2026
Renal fibrosis is induced by hyperactive Wnt/β-catenin pathway via microbial-mediated tryptophan metabolism-driven AhR signaling in rodents and humans.
Journal: Cellular and molecular life sciences : CMLS
Published: February 10, 2026
SUMOylation and NEDDylation in kidney diseases.
Journal: Experimental and molecular pathology
Published: September 12, 2025
Natural products targeting TGF-β/Smad signaling in renal fibrosis: Multiomics-based novel molecular mechanisms and therapeutic strategies.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: August 18, 2025
Targeting gut-liver-kidney axis: microbiota-derived metabolites and therapeutic implications.
Journal: Cell communication and signaling : CCS
Published: August 14, 2025
The role of mitochondrial-associated endoplasmic reticulum membranes (MAMs) in diabetic microvascular complications: a review.
Journal: Cell death & disease
Published: July 13, 2025
Urobiome of patients with diabetic kidney disease in different stages is revealed by 2bRAD-M.
Journal: Journal of translational medicine
Published: November 20, 2024
Mechanism and nanotechnological-based therapeutics for tolerance and resistance of bacterial biofilms.
Journal: Microbiological research
Published: July 31, 2024
Chaihuang Yishen Granule ameliorates mitochondrial homeostasis by upregulating PRDX5/TFAM axis to inhibit renal fibrosis in CKD.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: June 14, 2024
Targeting autophagy in diabetic cardiomyopathy: From molecular mechanisms to pharmacotherapy.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 10, 2024
Tangshen Formula alleviates inflammatory injury against aged diabetic kidney disease through modulating gut microbiota composition and related amino acid metabolism.
Journal: Experimental gerontology
Published: December 27, 2023
Tangshen formula targets the gut microbiota to treat non-alcoholic fatty liver disease in HFD mice: A 16S rRNA and non-targeted metabolomics analyses.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 26, 2023
Last Updated: 09/26/2026